The COVID-19 pandemic caused many businesses to close temporarily and socially distance to help slow the spread of the coronavirus.
Healthcare facilities shifted quickly to accommodate new guidelines and do their best to keep their patients safe.
We believe it is essential to understand better what healthcare professionals like and dislike about telehealth technologies.
Please see the full results of our survey about technology in healthcare below.

Bowel cancer immunotherapy trial shows no relapses, with NEOPRISM-CRC results at the American Association for Cancer Research.

Gene therapy restores hearing in patients with rare genetic deafness, with dfnb9 trial results showing long-term benefits up to 2.5 years.

Anemia in older adults tied to higher dementia risk, with blood biomarkers linked to Alzheimer’s disease signaling neurodegeneration.